Annual Total Liabilities
$617.71 M
+$16.59 M+2.76%
December 31, 2023
Summary
- As of February 7, 2025, FOLD annual total liabilities is $617.71 million, with the most recent change of +$16.59 million (+2.76%) on December 31, 2023.
- During the last 3 years, FOLD annual total liabilities has risen by +$17.57 million (+2.93%).
- FOLD annual total liabilities is now -8.72% below its all-time high of $676.69 million, reached on December 30, 2016.
Performance
FOLD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$607.73 M
-$9.23 M-1.50%
September 30, 2024
Summary
- As of February 7, 2025, FOLD quarterly total liabilities is $607.73 million, with the most recent change of -$9.23 million (-1.50%) on September 30, 2024.
- Over the past year, FOLD quarterly total liabilities has dropped by -$23.11 million (-3.66%).
- FOLD quarterly total liabilities is now -10.97% below its all-time high of $682.60 million, reached on March 31, 2017.
Performance
FOLD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
FOLD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.8% | -3.7% |
| 3 y3 years | +2.9% | -3.7% |
| 5 y5 years | +38.2% | -3.7% |
FOLD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +3.3% | -3.7% | +3.3% |
| 5 y | 5-year | at high | +65.3% | -3.7% | +81.0% |
| alltime | all time | -8.7% | >+9999.0% | -11.0% | +6714.7% |
Amicus Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $607.73 M(-1.5%) |
| Jun 2024 | - | $616.96 M(+4.4%) |
| Mar 2024 | - | $591.10 M(-4.3%) |
| Dec 2023 | $617.71 M(+2.8%) | $617.71 M(-2.1%) |
| Sep 2023 | - | $630.85 M(+2.0%) |
| Jun 2023 | - | $618.51 M(+3.4%) |
| Mar 2023 | - | $597.95 M(-0.5%) |
| Dec 2022 | $601.12 M(+0.6%) | $601.12 M(-4.1%) |
| Sep 2022 | - | $626.96 M(-0.0%) |
| Jun 2022 | - | $627.16 M(+6.6%) |
| Mar 2022 | - | $588.32 M(-1.6%) |
| Dec 2021 | $597.77 M(-0.4%) | $597.77 M(+3.1%) |
| Sep 2021 | - | $580.05 M(+1.2%) |
| Jun 2021 | - | $572.98 M(+2.5%) |
| Mar 2021 | - | $559.14 M(-6.8%) |
| Dec 2020 | $600.14 M(+60.6%) | $600.14 M(+3.4%) |
| Sep 2020 | - | $580.27 M(+70.4%) |
| Jun 2020 | - | $340.50 M(+1.4%) |
| Mar 2020 | - | $335.75 M(-10.2%) |
| Dec 2019 | $373.78 M(-16.4%) | $373.78 M(+11.9%) |
| Sep 2019 | - | $334.02 M(+5.0%) |
| Jun 2019 | - | $317.98 M(+1.6%) |
| Mar 2019 | - | $313.03 M(-30.0%) |
| Dec 2018 | $447.04 M(+63.0%) | $447.04 M(+4.5%) |
| Sep 2018 | - | $427.64 M(+62.0%) |
| Jun 2018 | - | $263.99 M(-24.2%) |
| Mar 2018 | - | $348.39 M(+27.1%) |
| Dec 2017 | $274.17 M(-59.5%) | $274.17 M(+1.1%) |
| Sep 2017 | - | $271.10 M(-59.7%) |
| Jun 2017 | - | $672.07 M(-1.5%) |
| Mar 2017 | - | $682.60 M(+0.9%) |
| Dec 2016 | $676.69 M(+20.7%) | $676.69 M(+16.3%) |
| Sep 2016 | - | $581.63 M(+0.3%) |
| Jun 2016 | - | $579.76 M(+5.2%) |
| Mar 2016 | - | $551.27 M(-1.7%) |
| Dec 2015 | $560.55 M | $560.55 M(-7.8%) |
| Sep 2015 | - | $607.94 M(+710.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $75.01 M(-15.3%) |
| Mar 2015 | - | $88.61 M(+0.9%) |
| Dec 2014 | $87.79 M(+7.3%) | $87.79 M(+6.8%) |
| Sep 2014 | - | $82.21 M(+0.6%) |
| Jun 2014 | - | $81.69 M(+0.5%) |
| Mar 2014 | - | $81.27 M(-0.7%) |
| Dec 2013 | $81.81 M(+100.2%) | $81.81 M(+92.0%) |
| Sep 2013 | - | $42.62 M(-0.4%) |
| Jun 2013 | - | $42.78 M(+7.3%) |
| Mar 2013 | - | $39.88 M(-2.4%) |
| Dec 2012 | $40.87 M(+1.7%) | $40.87 M(-1.4%) |
| Sep 2012 | - | $41.45 M(+7.9%) |
| Jun 2012 | - | $38.43 M(-4.0%) |
| Mar 2012 | - | $40.02 M(-0.4%) |
| Dec 2011 | $40.20 M(-15.6%) | $40.20 M(-4.5%) |
| Sep 2011 | - | $42.08 M(-7.9%) |
| Jun 2011 | - | $45.68 M(-7.7%) |
| Mar 2011 | - | $49.49 M(+3.9%) |
| Dec 2010 | $47.62 M(+251.8%) | $47.62 M(+258.8%) |
| Sep 2010 | - | $13.27 M(+26.1%) |
| Jun 2010 | - | $10.52 M(-24.5%) |
| Mar 2010 | - | $13.94 M(+3.0%) |
| Dec 2009 | $13.54 M(-76.6%) | $13.54 M(-78.1%) |
| Sep 2009 | - | $61.73 M(+2.8%) |
| Jun 2009 | - | $60.03 M(+7.0%) |
| Mar 2009 | - | $56.12 M(-2.8%) |
| Dec 2008 | $57.73 M(-9.5%) | $57.73 M(-4.0%) |
| Sep 2008 | - | $60.15 M(-2.1%) |
| Jun 2008 | - | $61.42 M(-0.7%) |
| Mar 2008 | - | $61.85 M(-3.1%) |
| Dec 2007 | $63.80 M(-53.5%) | $63.80 M(+472.5%) |
| Sep 2007 | - | $11.14 M(+25.0%) |
| Jun 2007 | - | $8.92 M(-94.4%) |
| Mar 2007 | - | $159.33 M(+16.2%) |
| Dec 2006 | $137.16 M(+112.7%) | $137.16 M(+112.7%) |
| Dec 2005 | $64.50 M(+1016.7%) | $64.50 M |
| Dec 2003 | $5.78 M | - |
FAQ
- What is Amicus Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics annual total liabilities year-on-year change?
- What is Amicus Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Amicus Therapeutics?
- What is Amicus Therapeutics quarterly total liabilities year-on-year change?
What is Amicus Therapeutics annual total liabilities?
The current annual total liabilities of FOLD is $617.71 M
What is the all time high annual total liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high annual total liabilities is $676.69 M
What is Amicus Therapeutics annual total liabilities year-on-year change?
Over the past year, FOLD annual total liabilities has changed by +$16.59 M (+2.76%)
What is Amicus Therapeutics quarterly total liabilities?
The current quarterly total liabilities of FOLD is $607.73 M
What is the all time high quarterly total liabilities for Amicus Therapeutics?
Amicus Therapeutics all-time high quarterly total liabilities is $682.60 M
What is Amicus Therapeutics quarterly total liabilities year-on-year change?
Over the past year, FOLD quarterly total liabilities has changed by -$23.11 M (-3.66%)